• Zenas BioPharma granted 51,075 restricted stock units to newly hired employees on May 15.
• The awards vest in four equal installments, with 25% scheduled to vest on May 15 in each year from 2027 through 2030.
• Vesting is contingent on continued service through each vesting date, under the company’s 2026 Inducement Plan and individual award agreements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenas Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605181615PRIMZONEFULLFEED9722291) on May 18, 2026, and is solely responsible for the information contained therein.